Content validity and ePRO usability of the BPI-sf and "worst pain" item with pleural and peritoneal mesothelioma

Journal of Patient-reported Outcomes
Heather L GelhornChris Sexton

Abstract

The Brief Pain Inventory-short form (BPI-sf) is widely used in self-reported pain assessment, incorporates pain numeric rating scales (NRS) and is commonly utilized in electronic format in clinical trials, however, there is no published information about its usability as an electronic patient-reported outcome (ePRO) measure. The objective of this qualitative study was threefold: 1) to better understand pain experiences among patients with pleural or peritoneal mesothelioma; 2) to assess the interpretability of the instructions, item stem, recall period, and response option of the "worst pain" item of the BPI-sf; and 3) to examine the usability of the TrialMax Touch™ (CRF Health, Inc., Plymouth Meeting, PA) screen-based handheld device and the electronic format of the BPI-sf in a sub-sample of pleural mesothelioma patients. A cross-sectional qualitative study was conducted among participants with pleural and peritoneal mesothelioma recruited from 4 clinical sites in the US. Semi-structured telephone or in-person interviews were conducted consisting of concept elicitation, cognitive interviewing of the 11-item BPI-sf, and in-person interview evaluation of ePRO assessment usability in pleural mesothelioma patients. Twenty-one part...Continue Reading

References

Jul 7, 2005·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Patricia J HollenJames J Rusthoven
Oct 26, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Charles S Cleeland
Dec 19, 2007·International Journal of Occupational and Environmental Health·Theodore LarsonPatricia Jamison
Apr 3, 2008·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Chad J GwaltneySaul Shiffman
Aug 5, 2008·Journal of Pain and Symptom Management·Qiuling ShiCharles S Cleeland
Dec 23, 2008·Orphanet Journal of Rare Diseases·Alastair J MooreJohn Wiggins
Sep 1, 2009·The European Respiratory Journal·A ScherpereelUNKNOWN European Respiratory Society/European Society of Thoracic Surgeons Task Force
Nov 11, 2009·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Stephen Joel CoonsUNKNOWN ISPOR ePRO Task Force
May 15, 2010·Critical Reviews in Oncology/hematology·Jan P van MeerbeeckPaul Baas
Jun 29, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R A StahelUNKNOWN ESMO Guidelines Working Group
Jul 9, 2010·Journal of Clinical Epidemiology·Nicholas BellamyUNKNOWN EDC Study Group
Jul 28, 2010·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Nancy Kline LeidyUNKNOWN EXACT-PRO Study Group
Apr 6, 2011·Environmental Health Perspectives·Eun-Kee ParkTom Sorahan
Oct 14, 2011·Health and Quality of Life Outcomes·Adam GaterElisabeth C Piault
Aug 17, 2014·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Sonya EremencoUNKNOWN ISPOR PRO Mixed Modes Task Force
Jul 28, 2015·The Cochrane Database of Systematic Reviews·José S Marcano BelisarioJosip Car

❮ Previous
Next ❯

Citations

Sep 7, 2018·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Loretta A WilliamsCharles S Cleeland

❮ Previous
Next ❯

Software Mentioned

SAS
ATLAS
ti
TrialMax

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.